Ground Swell Capital’s Bionano Genomics BNGO Stock Holding History

Ground Swell Capital’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20	Closed	-$88K	–	75
2021 Q2	$88K	Buy	+20	New	+$79K	0.42%	59

Other funds holding BNGO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $33.2B AUM 25.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Ground Swell Capital's BNGO Position: Q3 2021 in Review

Ground Swell Capital sold out of Bionano Genomics (BNGO) in Q3 2021, closing a stake of 20 shares — an estimated $88K sold.

Ground Swell Capital first reported a position in BNGO in Q2 2021 and held it in 1 quarter. The position peaked at $88K in Q2 2021. 147 funds tracked by Wall St. Rank hold BNGO as of Q3 2021.

Ground Swell Capital reported no remaining Bionano Genomics position as of Q3 2021 after selling out during the quarter.
Ground Swell Capital sold 20 Bionano Genomics shares in Q3 2021, an estimated $88K.
Ground Swell Capital first reported a position in Bionano Genomics in Q2 2021 and held it in 1 quarter.
Ground Swell Capital's Bionano Genomics position peaked at $88K in Q2 2021.
147 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2021.

Based on Ground Swell Capital's 13F filing for Q3 2021, filed 12 Nov 2021.